Showing 1 - 20 results of 29 for search 'Ralph Mösges', query time: 0.07s Refine Results
  1. 1
    Worldwide surveys on anaphylaxis to sublingual immunotherapy with house dust mite tablets are urgently needed

    Worldwide surveys on anaphylaxis to sublingual immunotherapy with house dust mite tablets are urgently needed by Ralph Mösges, Desiderio Passali, Mario Di Gioacchino

    Published 2021-03-01
    Get full text
    Article
  2. 2
    Characterisation of patients receiving moxifloxacin for acute bacterial rhinosinusitis in clinical practice: results from an international, observational cohort study.

    Characterisation of patients receiving moxifloxacin for acute bacterial rhinosinusitis in clinical practice: results from an international, observational cohort study. by Ralph Mösges, Martin Desrosiers, Pierre Arvis, Stephanie Heldner

    Published 2013-01-01
    Get full text
    Article
  3. 3
    A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio

    A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio by Oliver Pfaar, Angelika Sager, Ralph Mösges, Margitta Worm

    Published 2023-11-01
    Get full text
    Article
  4. 4
    Debates in Allergy Medicine: Allergy skin testing cannot be replaced by molecular diagnosis in the near future

    Debates in Allergy Medicine: Allergy skin testing cannot be replaced by molecular diagnosis in the near future by Désirée Larenas-Linnemann, Jorge A. Luna-Pech, Ralph Mösges

    Published 2017-09-01
    Get full text
    Article
  5. 5
    Rhinosinusitis Treatment with Cineole: Patient-Reported Quality of Life Improvements from a Non-Interventional, Pharmacy-Based Survey

    Rhinosinusitis Treatment with Cineole: Patient-Reported Quality of Life Improvements from a Non-Interventional, Pharmacy-Based Survey by Nina Werkhäuser, Ursula Pieper-Fürst, Hacer Sahin, Antonia Claas, Ralph Mösges

    Published 2023-06-01
    Get full text
    Article
  6. 6
    Ivy leaves extract EA 575 in the treatment of cough during acute respiratory tract infections: meta-analysis of double-blind, randomized, placebo-controlled trials

    Ivy leaves extract EA 575 in the treatment of cough during acute respiratory tract infections: meta-analysis of double-blind, randomized, placebo-controlled trials by Andreas Völp, Jennifer Schmitz, Michael Bulitta, Esther Raskopf, Cengizhan Acikel, Ralph Mösges

    Published 2022-11-01
    Get full text
    Article
  7. 7
    Effectiveness of Ectoin lozenges on oropharyngeal allergic symptoms

    Effectiveness of Ectoin lozenges on oropharyngeal allergic symptoms by Rawan Khachouk, Ursula Pieper‐Fürst, Cengizhan Acikel, Carina Kolot, Andreas Bilstein, Ralph Mösges

    Published 2022-01-01
    Get full text
    Article
  8. 8
    Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis

    Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis by Anne M. Salapatek, Nina Werkhäuser, Basma Ismail, Ralph Mösges, Esther Raskopf, Andreas Bilstein

    Published 2021-03-01
    Get full text
    Article
  9. 9
    On the Sustainability of Guideline Implementation

    On the Sustainability of Guideline Implementation by Juliane Köberlein, PhD, Julia Vent, MD, PhD, Ralph Mösges, FAAAAI, MD, PhD

    Published 2010-01-01
    Get full text
    Article
  10. 10
    Effectiveness and Tolerability of Ectoin<sup>®</sup> Mouth and Throat Spray Althaea Honey (ERS09) for Sore Throat due to Acute Pharyngitis and Dry Cough: A Multicentre, Actively Controlled, Open Label Study in Germany

    Effectiveness and Tolerability of Ectoin<sup>®</sup> Mouth and Throat Spray Althaea Honey (ERS09) for Sore Throat due to Acute Pharyngitis and Dry Cough: A Multicentre, Actively Co... by Don Lorenzo Constantin Roventa, Ursula Pieper-Fürst, Cengizhan Acikel, Dunia Santos, Ulrike Sent, Ralph Mösges

    Published 2023-09-01
    Get full text
    Article
  11. 11
    Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis

    Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis by Ralph Mösges, Antonio Valero Santiago, Silke Allekotte, Nilufar Jahed, Anatoli Astvatsatourov, Angelika Sager, Jaime Sánchez-López

    Published 2019-06-01
    Get full text
    Article
  12. 12
    International Delphi-based consensus on the appropriate use and effect of Benzydamine hydrochloride in the treatment of sore throat

    International Delphi-based consensus on the appropriate use and effect of Benzydamine hydrochloride in the treatment of sore throat by Desiderio Passali, Veronica Barat, Olga Cadevall, Hugo Miguel Freire, Ignazio Grattagliano, Ioan Gutu, Ralph Mösges, Andrey Pavlysh

    Published 2022-11-01
    Get full text
    Article
  13. 13
    Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners

    Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitio... by Desiderio Passali, Maria Felice Arezzo, Alessandra De Rose, Gianmarco De Simone, Gianluigi Forte, Michalina Jablko-Musial, Ralph Mösges

    Published 2022-06-01
    Get full text
    Article
  14. 14
    Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients

    Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients by Christiane Dings, Peter Meiser, Frank Holzer, Michael Flegel, Dominik Selzer, Eszter Nagy, Ralph Mösges, Jens Peter Klussmann, Thorsten Lehr

    Published 2022-09-01
    Get full text
    Article
  15. 15
    Validation of AI-based software for objectification of conjunctival provocation test

    Validation of AI-based software for objectification of conjunctival provocation test by Yury Yarin, PhD, Alexandra Kalaitzidou, BSc, Kira Bodrova, BSc, Ralph Mösges, MD, PhD, Yannis Kalaidzidis, PhD

    Published 2023-08-01
    Get full text
    Article
  16. 16
    Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis

    Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis by Binoy Palathumpattu, Ursula Pieper‐Fürst, Cengizhan Acikel, Hacer Sahin, Silke Allekotte, Jaswinder Singh, Mark Hess, Angelika Sager, Thomas Müller, Ralph Mösges

    Published 2022-10-01
    Get full text
    Article
  17. 17
    A meta‐analysis on allergen‐specific immunotherapy using MCT® (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis

    A meta‐analysis on allergen‐specific immunotherapy using MCT® (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctiviti... by Sven Becker, Petra Zieglmayer, Gabriela Canto, Filippo Fassio, Patrick Yong, Cengizhan Acikel, Esther Raskopf, Esther Helen Steveling‐Klein, Silke Allekotte, Ralph Mösges

    Published 2021-06-01
    Get full text
    Article
  18. 18
    Early nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy

    Early nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy by Janina Köther, Alicia Mandl, Silke Allekotte, Anatoli Astvatsatourov, Janin Chwieralski, Jan-Patrick Liedtke, Ursula Pieper-Fürst, Esther Raskopf, Kija Shah-Hosseini, Ralph Mösges

    Published 2018-07-01
    Get full text
    Article
  19. 19
    Short-Course Allergen-Specific Immunotherapy with Modified Grass/Tree Allergoids Using a Microcrystalline Tyrosine (MCT®) and Monophosphoryl Lipid A (MPL) Adjuvant System Decreases Specific Immunoglobulin E Levels

    Short-Course Allergen-Specific Immunotherapy with Modified Grass/Tree Allergoids Using a Microcrystalline Tyrosine (MCT®) and Monophosphoryl Lipid A (MPL) Adjuvant System Decreases... by Dietrich Stollewerk, Marion Niebecker, Elisa Fuchs, Laura England, Hacer Şahin, Silke Allekotte, Ralph Mösges, Jennifer Raab, Matthias F. Kramer, Jennifer Speda, Katrin Birkholz

    Published 2022-12-01
    Get full text
    Article
  20. 20
    Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season

    Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season by Ralph Mösges, Nils Y. Breitrück, Silke Allekotte, Kija Shah-Hosseini, Van-Anh Dao, Petra Zieglmayer, Katrin Birkholz, Mark Hess, Maximilian Bastl, Katharina Bastl, Uwe Berger, Matthias F. Kramer, Sonja Guethoff

    Published 2019-01-01
    Get full text
    Article

Search Tools: